Pyruvate Identified As A Promising Oral Treatment For Ulcerative Colitis

Ulcerative colitis (UC) is simply a chronic inflammatory illness marked by intestinal pain, bleeding, and impaired gut obstruction function. At nan bosom of nan illness lies TNFα-induced NF-κB signaling, which drives nan accumulation of cytokines for illustration IL-6 and IL-1β and disrupts tight junction proteins captious for gut integrity. While existent treatments specified arsenic corticosteroids and biologics suppress inflammation, they often bring broadside effects and require injection-based delivery. These limitations person prompted increasing liking successful orally available, low-toxicity mini molecules that tin modulate some immune signaling and mucosal health. Due to these challenges, location is simply a increasing request to research replacement therapeutics and decode their mechanisms successful UC management.

In a study (DOI: 10.1016/j.gendis.2025.101571) published connected June 19, 2025, successful Genes & Diseases, researchers from New York University Grossman School of Medicine, Rutgers University, and Yale School of Medicine unveiled that exogenous pyruvate tin efficaciously dainty murine colitis by blocking TNFα/NF-κB signaling and straight targeting cytosolic phospholipase A2 (cPLA2). This investigation not only identifies a powerful anti-inflammatory system but besides spotlights pyruvate arsenic a promising oral campaigner for inflammatory bowel illness therapy.

The squad began by screening various cellular metabolites for their expertise to inhibit TNFα-induced inflammatory cistron look successful immune cells. Pyruvate emerged arsenic nan astir effective, reducing cardinal cytokines specified arsenic IL-1β, IL-6, and CCL2 successful some RAW 264.7 macrophages and bony marrow-derived macrophages. In mice pinch DSS-induced colitis, oral pyruvate dramatically reduced illness symptoms, including assemblage weight loss, rectal bleeding, and colon inflammation. Crucially, pyruvate preserved intestinal obstruction usability by restoring tight junction proteins for illustration ZO-1 and occludin, while suppressing pro-inflammatory cytokines. To uncover really pyruvate exerts its effects, nan researchers utilized supplier affinity-responsive target stableness (DARTS) and cellular thermal displacement assays (CETSA), revealing cPLA2 arsenic a caller nonstop binding target. In genetically engineered mice lacking cPLA2, pyruvate's protective effects were mostly abolished, confirming that its therapeutic action relies connected cPLA2 inhibition. This dual benefit—anti-inflammatory action and obstruction protection—positions pyruvate arsenic a unique, multifunctional therapeutic candidate.

Source:

Journal reference:

Hasan, S., et al. (2025). Exogenous pyruvate is therapeutic against colitis by targeting cytosolic phospholipase A2. Genes & Diseases. doi.org/10.1016/j.gendis.2025.101571.